VirginIslandsEverything ๐Ÿ”ฅ Viral

Last Day to Claim $475M Drug Price Settlement for Virgin Islands Residents

Islanders who bought generic medications between 2009 and 2019 must file by November 9 to share in compensation from two major pharmaceutical cases.

A collection of generic prescription pill bottles and pharmacy receipts arranged on a desk with the US Virgin Islands flag in the background, soft natural lighting, professional composition
Illustration (AI-generated)

Residents of the U.S. Virgin Islands have one final day to request compensation from two major pharmaceutical settlements worth $475 million combined, according to court filings and settlement administrators.

The money stems from legal cases accusing drug makers of using anticompetitive practices to artificially inflate prices for generic medications, forcing consumers and insurers to pay inflated costs. Two separate agreements are involved: one for $275 million covering Sandoz Inc. and Fougera Pharmaceuticals Inc., and another for $200 million involving Sun Pharmaceutical Industries Inc. and Taro Pharmaceuticals U.S.A. Inc. Both companies have maintained they did not engage in wrongdoing, and the settlements do not constitute admissions of liability.

Virgin Islanders who purchased eligible generic drugs out of pocket or through insurance copayments between May 1, 2009, and December 31, 2019, may be entitled to a share. Medicaid-covered prescriptions, drugs bought directly from the manufacturers, and medications purchased for resale do not qualify.

The settlement covers approximately 197 categories of generic medications. Common drugs on the eligible list include albuterol, allopurinol, amitriptyline, doxycycline, levothyroxine, glimepiride, warfarin and extended-release metformin. However, not all versions or strengths of these medications qualify, so residents must verify their specific purchases against the official drug list before filing.

Claims can be submitted online at GenericDrugsEndPayerSettlement.com or by mail. Those filing electronically must upload documentation proving at least one purchase of each medication claimed, such as pharmacy receipts, invoices, account statements or itemized purchase histories. Mailed forms must be postmarked by November 9 and sent to: In re: Generic Pharmaceuticals Pricing Antitrust Litigation, c/o A.B. Data Ltd., P.O. Box 173118, Milwaukee, WI 53217.

The settlement administrator cautions that incomplete online submissions cannot be saved for later completion and recommends using a desktop or laptop computer if mobile users encounter technical problems. Assistance is available by calling 1-877-316-0171 or emailing through the website.

No fixed payment amount is guaranteed. Approved claimants will receive a proportional distribution based on how much they spent and the total number of valid claims received. Court-approved expenses, attorney fees and administration costs are deducted before payments are distributed. Claimants can receive funds through direct deposit, Zelle, PayPal, Venmo or check.

How does this story make you feel?

Sources The Virgin Islands Consortium

๐Ÿ“ฃ Know more about this story? Send us a tip. Photos welcome. Your identity stays private.

Comments

No comments yet. Be the first.

Create a comment

Comments are checked before they appear.